Skip to main content

Q2 earnings

By Dave Muoio | 02:29 pm | July 30, 2020
Although the company's rapid growth has been fueled by COVID-19, new contracts and state-by-state trends have CEO Jason Gorevic confident that telehealth adoption is here to stay.
By Dave Muoio | 03:22 pm | August 09, 2019
The company laid off more than half of its staff since the beginning of 2019.
By Dave Muoio and Jonah Comstock | 04:06 pm | May 01, 2019
Also: uBiome's FBI investigation; Better Therapeutics' pivotal trial plans.